|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||
| Cash | ||||||||||||||||
| Prepaid expenses | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Cash and marketable securities held in the Trust Account | ||||||||||||||||
| Total Assets | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accrued expenses | ||||||||||||||||
| Promissory note – related party | ||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||
| Due to related party | ||||||||||||||||
| Convertible promissory notes - related party | ||||||||||||||||
| Related party | ||||||||||||||||
| Total convertible promissory notes - related party | ||||||||||||||||
| Excise tax payable | ||||||||||||||||
| Income tax payable | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Deferred underwriting fee | ||||||||||||||||
| Warrant liability | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Class A common stock subject to possible redemption, 2,998,436 and 3,900,717 shares issued and outstanding at redemption value of $11.31 and $10.82 at September 30, 2024 and December 31, 2023, respectively | ||||||||||||||||
| Class A Common Stock | ||||||||||||||||
| Total class A common stock subject to possible redemption, 2,998,436 and 3,900,717 shares issued and outstanding at redemption value of $11.31 and $10.82 at September 30, 2024 and December 31, 2023, respectively | ||||||||||||||||
| Stockholders’ Deficit | ||||||||||||||||
| Common stock value | ||||||||||||||||
| Class A Common Stock | ||||||||||||||||
| Class B Common Stock | ||||||||||||||||
| Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,737,500 shares issued and outstanding at March 31, 2023 and December 31, 2022 | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||
| Total Liabilities, Class A Common Stock Subject to Possible Redemption, and Stockholders’ Deficit | ||||||||||||||||
Loading...